SZSE:300601 (China)
Â
Class A
Â¥
20.20
(-0.83%)
Apr 30
Business Description
Shenzhen Kangtai Biological Products Co Ltd
ISIN : CNE100002Q33
Share Class Description:
SZSE:300601: Class ACompare
Compare
Traded in other countries / regions
300601.China IPO Date
2017-02-07Description
Shenzhen Kangtai Biological Products Co Ltd is a human vaccine research and development company. The company is engaged in the research and development, production and sales of recombinant hepatitis B vaccine, b -type influenza Haemophilus conjugate vaccine, measles-rubella combined live attenuated vaccine, cell-free baibai broke b Haemophilus influenzae vaccine and other products.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.38 | |||||
| Equity-to-Asset | 0.64 | |||||
| Debt-to-Equity | 0.27 | |||||
| Debt-to-EBITDA | 2.98 | |||||
| Interest Coverage | 8.14 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 3.3 | |||||
| Beneish M-Score | -2.4 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 13.9 | |||||
| 3-Year EBITDA Growth Rate | 11.7 | |||||
| 3-Year EPS without NRI Growth Rate | 4.2 | |||||
| 3-Year Book Growth Rate | 7.9 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.87 | |||||
| 9-Day RSI | 43.64 | |||||
| 14-Day RSI | 41.2 | |||||
| 6-1 Month Momentum % | -27.83 | |||||
| 12-1 Month Momentum % | -27.78 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.82 | |||||
| Quick Ratio | 1.49 | |||||
| Cash Ratio | 0.36 | |||||
| Days Inventory | 597.74 | |||||
| Days Sales Outstanding | 307.32 | |||||
| Days Payable | 483.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.89 | |||||
| Dividend Payout Ratio | 0.23 | |||||
| 3-Year Dividend Growth Rate | -1.4 | |||||
| Forward Dividend Yield % | 0.89 | |||||
| 5-Year Yield-on-Cost % | 4.6 | |||||
| 3-Year Average Share Buyback Ratio | -0.6 | |||||
| Shareholder Yield % | 0.88 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 84.15 | |||||
| Operating Margin % | 30.44 | |||||
| Net Margin % | 22.32 | |||||
| FCF Margin % | 4.02 | |||||
| ROE % | 7.52 | |||||
| ROA % | 4.87 | |||||
| ROIC % | 7.96 | |||||
| ROC (Joel Greenblatt) % | 11.66 | |||||
| ROCE % | 7.32 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 62.54 | |||||
| PE Ratio without NRI | 51.4 | |||||
| Shiller PE Ratio | 43.26 | |||||
| PS Ratio | 7.02 | |||||
| PB Ratio | 2.35 | |||||
| Price-to-Tangible-Book | 2.48 | |||||
| Price-to-Free-Cash-Flow | 183.64 | |||||
| Price-to-Operating-Cash-Flow | 27.22 | |||||
| EV-to-EBIT | 61.2 | |||||
| EV-to-EBITDA | 61.2 | |||||
| EV-to-Revenue | 7.92 | |||||
| EV-to-FCF | 189.03 | |||||
| Price-to-Projected-FCF | 6.89 | |||||
| Price-to-Graham-Number | 1.67 | |||||
| Earnings Yield (Greenblatt) % | 1.63 | |||||
| FCF Yield % | 0.53 | |||||
| Forward Rate of Return (Yacktman) % | 17.56 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shenzhen Kangtai Biological Products Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 3,180.715 | ||
| EPS (TTM) (Â¥) | 0.64 | ||
| Beta | 1.77 | ||
| Volatility % | 41.59 | ||
| 14-Day RSI | 41.2 | ||
| 14-Day ATR (Â¥) | 0.736825 | ||
| 20-Day SMA (Â¥) | 20.787 | ||
| 12-1 Month Momentum % | -27.78 | ||
| 52-Week Range (Â¥) | 18.44 - 34.18 | ||
| Shares Outstanding (Mil) | 1,116.92 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shenzhen Kangtai Biological Products Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shenzhen Kangtai Biological Products Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shenzhen Kangtai Biological Products Co Ltd Frequently Asked Questions
What is Shenzhen Kangtai Biological Products Co Ltd(SZSE:300601)'s stock price today?
The current price of SZSE:300601 is ¥20.20. The 52 week high of SZSE:300601 is ¥34.18 and 52 week low is ¥18.44.
When is next earnings date of Shenzhen Kangtai Biological Products Co Ltd(SZSE:300601)?
The next earnings date of Shenzhen Kangtai Biological Products Co Ltd(SZSE:300601) is .
Does Shenzhen Kangtai Biological Products Co Ltd(SZSE:300601) pay dividends? If so, how much?
The Dividend Yield %  of Shenzhen Kangtai Biological Products Co Ltd(SZSE:300601) is 0.89% (As of Today), Highest Dividend Payout Ratio of Shenzhen Kangtai Biological Products Co Ltd(SZSE:300601) was 0.33. The lowest was 0.12. And the median was 0.23. The  Forward Dividend Yield % of Shenzhen Kangtai Biological Products Co Ltd(SZSE:300601) is 0.89%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers